• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sidus Space Appoints Bill White as Chief Financial Officer

    2/8/24 8:30:00 AM ET
    $PRPH
    $SIDU
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $PRPH alert in real time by email

    Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), a multi-faceted Space and Data-as-a-Service company, today announced the appointment of Bill White as Chief Financial Officer, effective February 20, 2024.

    Mr. White will oversee the Company's accounting, financial planning, capital raise, treasury, legal and regulatory functions. Mr. White has more than 30 years of experience in financial management, operations, and business development. He most recently served as Chief Financial Officer of ProPhase Labs, Inc. (NASDAQ:PRPH) and prior to ProPhase he was CFO, treasurer, and secretary of Intellicheck, Inc., a technology company listed on the NasdaqGM. Mr. White has broad domestic and international experience including managing rapid and significant growth, import/export, implementing tough cost management initiatives, exploiting new growth opportunities, mergers and acquisitions, strategic planning, resource allocation, tax compliance and organization development.

    "Bill's deep experience as a public company executive alongside his remarkable proficiency in capital markets and M&A, aligns perfectly with the current stage of Sidus' growth," said Carol Craig, Chief Executive Officer of Sidus.

    "I am honored to serve Sidus at this critical time in its growth and evolution and am excited to work with Carol and the management team to capitalize upon the growth opportunities ahead and deliver long-term value for shareholders," said Bill White, incoming Chief Financial Officer.

    Teresa Burchfield has confirmed her intention to step down as Chief Financial Officer after two years with the Company. Burchfield will remain with the Company, serving in an advisory role, to assist White with the transition.

    Craig added, "I have enjoyed working with Teresa and, during her tenure as chief financial officer at the Company, she has made innumerable and invaluable contributions to its success and growth. On behalf of the Board and the entire Sidus team, I'd like to thank Teresa for her valuable contributions and for laying the groundwork for our continued growth in the public and space sectors."

    About Sidus Space

    Sidus Space (NASDAQ:SIDU) is a Space and Data-as-a-Service satellite company focused on mission-critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support. The Company is located in Cape Canaveral, Florida, where it operates from a 35,000-square-foot manufacturing, assembly, integration, and testing facility focused on vertically integrated Space-as-a-Service solutions including end-to-end satellite support.

    Sidus Space has a mission of Bringing Space Down to Earth™ and a vision of enabling space flight heritage status for new technologies while delivering data and predictive analytics to domestic and global customers. Any corporation, industry, or vertical can start their journey off-planet with Sidus Space's rapidly scalable, low-cost satellite services, space-based solutions, and testing alternatives. More than just a "Satellite-as-a-Service" provider, Sidus Space is a trusted Mission Partner–from concept to Low Earth Orbit and beyond. Sidus Space is ISO 9001:2015, AS9100 Rev. D certified, and ITAR registered.

    Forward-Looking Statements

    Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute ‘forward-looking statements' within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words ‘anticipate,' ‘believe,' ‘continue,' ‘could,' ‘estimate,' ‘expect,' ‘intend,' ‘may,' ‘plan,' ‘potential,' ‘predict,' ‘project,' ‘should,' ‘target,' ‘will,' ‘would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors' in Sidus Space's Annual Report on Form 10-K for the year ended December 31, 2022, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Sidus Space, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240208062368/en/

    Get the next $PRPH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRPH
    $SIDU

    CompanyDatePrice TargetRatingAnalyst
    ProPhase Labs Inc.
    $PRPH
    1/14/2022$12.00 → $15.00Buy
    HC Wainwright & Co.
    ProPhase Labs Inc.
    $PRPH
    12/20/2021$12.00Buy
    HC Wainwright & Co.
    ProPhase Labs Inc.
    $PRPH
    10/13/2021Buy → Neutral
    Dawson James
    More analyst ratings

    $PRPH
    $SIDU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

    4 - Sidus Space Inc. (0001879726) (Issuer)

    6/13/25 4:15:18 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $PRPH
    $SIDU
    SEC Filings

    View All

    ProPhase Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - ProPhase Labs, Inc. (0000868278) (Filer)

    9/18/25 4:05:46 PM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sidus Space Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Sidus Space Inc. (0001879726) (Filer)

    9/16/25 6:03:22 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    SEC Form 424B5 filed by Sidus Space Inc.

    424B5 - Sidus Space Inc. (0001879726) (Filer)

    9/15/25 5:12:38 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $PRPH
    $SIDU
    Leadership Updates

    Live Leadership Updates

    View All

    Sidus Space Appoints Lawrence Hollister as Chief Business Officer to Drive Strategic Growth and Market Expansion

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced the appointment of Lawrence Hollister as its new Chief Business Officer, effective September 15, 2025, to accelerate growth across commercial and government markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915521625/en/Sidus Space Appoints Lawrence Hollister as Chief Business Officer Mr. Hollister joins Sidus with a distinguished track record of driving revenue growth, scaling operations, and executing strategic initiatives across defense, aerospace, intelligence, cyber, and federal civil sectors.

    9/15/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Sidus Space Appoints Tech Entrepreneur and Global Business Leader Tiffany Norwood to its Board of Directors

    Norwood brings decades of experience in global fundraising, frontier tech innovation, and entrepreneurial leadership Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced the appointment of Tiffany Norwood to its Board of Directors. Norwood is a globally recognized serial entrepreneur and technology pioneer with more than 35 years of experience launching disruptive innovations across the space, telecommunications, digital media, and fintech sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250722804451/en/Sidus Space Appoints Tech Entrepreneur and Globa

    7/22/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 18, 2025 /PRNewswire/ -- USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer. In fact, the report cites a recent study from the National Institutes of Health (NIH), which found that between 2010 and 2019, more than 2 million Americans aged 15 to 49 were diagnosed with cancer, with early-onset cases rising significantly in 14 different cancer types, including breast, colorectal, and kidney cancers. The dire statistics from the study come at a time where Bloomberg has recently reported on the skyrocketing costs of cancer drugs,

    6/18/25 11:19:00 AM ET
    $CATX
    $CGON
    $GALT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Biotechnology: Pharmaceutical Preparations

    $PRPH
    $SIDU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CEO & CHAIRMAN Karkus Ted William

    4 - ProPhase Labs, Inc. (0000868278) (Issuer)

    9/11/25 4:05:22 PM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Oliver John Cole converted options into 8,936 shares (SEC Form 4)

    4 - Sidus Space Inc. (0001879726) (Issuer)

    8/4/25 5:30:18 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Director Shuman Jeffrey S converted options into 15,686 shares, increasing direct ownership by 105% to 30,686 units (SEC Form 4)

    4 - Sidus Space Inc. (0001879726) (Issuer)

    8/4/25 5:30:20 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $PRPH
    $SIDU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HC Wainwright & Co. reiterated coverage on ProPhase Labs with a new price target

    HC Wainwright & Co. reiterated coverage of ProPhase Labs with a rating of Buy and set a new price target of $15.00 from $12.00 previously

    1/14/22 6:36:15 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HC Wainwright & Co. initiated coverage on ProPhase Labs with a new price target

    HC Wainwright & Co. initiated coverage of ProPhase Labs with a rating of Buy and set a new price target of $12.00

    12/20/21 6:25:15 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ProPhase downgraded by Dawson James

    Dawson James downgraded ProPhase from Buy to Neutral

    10/13/21 10:48:44 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PRPH
    $SIDU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sidus Space Awarded Five-Year IDIQ Contract to Support Tobyhanna Army Depot

    Sidus Space (NASDAQ: SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced it has been awarded a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract under the Tobyhanna Army Depot (TYAD) Industrial Multiple Award Task Order Contract (MATOC) program. This award enables Sidus Space to provide fabrication and on-call services for critical components used in TYAD's operations, including: Electrical Harnesses and Cable Assemblies Mechanical Components and Assemblies Welding Services The IDIQ contract carries a ceiling value of $21 million over five years with individual Task Orders capped at $750,000. The contract enabl

    9/29/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE

    COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next generation biotech, genomics and consumer products company, announced that its three COVID-19 testing laboratory companies filed for reorganization under Chapter 11 in United States Bankruptcy Court for the District of New Jersey, advancing the Crown Medical Collections initiative to the key next step. This bankruptcy action is strictly limited to the Company's COVID-19 lab testing units, which are collectively owed tens of millions of dollars by insurance companies. Successful collections have th

    9/23/25 8:00:00 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ProPhase Continues its Exploration of a Crypto Treasury Strategy

    UNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next generation biotech, genomics and consumer products company, announced that the Company entered into an agreement relating to potential advisory services. Management continues to evaluate a range of options for potential allocation of balance sheet resources, including the possibility of investing in digital assets. "Following our stockholders' approval of all proxy items at the September 9 Special Meeting, ProPhase is now positioned to advance its crypto treasury strategy," said Ted Karkus, CEO and Chairman of ProPhase Labs. "We believe that we have significant underly

    9/22/25 8:00:00 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PRPH
    $SIDU
    Financials

    Live finance-specific insights

    View All

    Sidus Space Reports Second Quarter 2025 Financial Results and Provides Business Update

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced its financial results for the second quarter ended June 30, 2025, and provided a business update. The Company is scheduled to host a conference call and webcast today, Thursday, August 14, at 5:00 p.m. ET. "Q2 was about disciplined execution and building durable technology assets. We advanced LizzieSat®‑3 commissioning, fully staffed our 24/7 Mission Operations Center, and expanded our proprietary platform with the Fortis™ VPX Command and Data Handling system and Orlaith™ AI Ecosystem, built to move data and insights seamlessly across space, air, land, and sea," said

    8/14/25 4:45:00 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025

    ProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company granted key U.S. patent on BE-Smart™ Esophageal Adenocarcinoma Risk Assessment test (August 2025) Company to hold a virtual conference call Wednesday, August 13, 2025, at 2:00 PM ET UNIONDALE, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a diversified diagnostics, genomics, and consumer healthcare company, today reported financial and operational results for the three and six months ended June 30, 2025. Ted Karkus, CEO of ProPhase Labs, will present to s

    8/13/25 8:00:00 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025

    UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase"), a next generation biotech, genomics and consumer products company, announced today that they will be presenting second quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on August 13, 2025, at 2:00 pm EDT. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event. Investors interested in participating in this live event will need to register using the link below. After the event, a re

    8/11/25 8:00:00 AM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PRPH
    $SIDU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    6/28/24 4:13:44 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    SEC Form SC 13D/A filed by ProPhase Labs Inc. (Amendment)

    SC 13D/A - ProPhase Labs, Inc. (0000868278) (Subject)

    3/19/24 4:18:00 PM ET
    $PRPH
    Biotechnology: Pharmaceutical Preparations
    Health Care